{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T10:45:05Z","timestamp":1781865905557,"version":"3.54.5"},"reference-count":39,"publisher":"Akademiai Kiado Zrt.","issue":"4","license":[{"start":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T00:00:00Z","timestamp":1611446400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2021,1,24]]},"abstract":"<jats:p><jats:bold>\u00d6sszefoglal\u00f3.<\/jats:bold> Az als\u00f3 h\u00fagyutak f\u0151 funkci\u00f3ja a vizelet t\u00e1rol\u00e1sa \u00e9s\n                    \u00fcr\u00edt\u00e9se, amely m\u0171k\u00f6d\u00e9sek zavara az \u00fagynevezett als\u00f3 h\u00fagy\u00fati t\u00fcnetegy\u00fcttes\n                    kialakul\u00e1s\u00e1hoz vezet, ami a kiv\u00e1lt\u00f3 okt\u00f3l f\u00fcgg\u0151en vizelet\u00fcr\u00edt\u00e9si zavarral \u00e9s\n                    vizeletretenci\u00f3val is j\u00e1rhat. Kezeletlen esetekben a fels\u0151 h\u00fagyutak k\u00e1rosod\u00e1sa\n                    k\u00f6vetkezik be a magas h\u00f3lyagnyom\u00e1s \u00e1ltal kiv\u00e1ltott vesicoureteralis reflux\n                    k\u00f6vetkezt\u00e9ben, amely ureter- \u00e9s vese\u00fcregrendszeri t\u00e1gulat kialakul\u00e1s\u00e1ra, illetve\n                    fert\u0151z\u00e9sekre \u00e9s k\u0151k\u00e9pz\u0151d\u00e9sre hajlamos\u00edt. A vizelett\u00e1rol\u00e1si\/vizelet\u00fcr\u00edt\u00e9si\n                    zavarokat h\u00e1rom f\u0151 csoportba sorolhatjuk, \u00fagymint stressz- (terhel\u00e9ses)\n                    inkontinencia , hiperakt\u00edv h\u00f3lyag (nedves\/sz\u00e1raz) \u00e9s neurog\u00e9n h\u00f3lyag. A jelen\n                    \u00f6sszefoglal\u00f3 k\u00f6zlem\u00e9ny t\u00e1rgy\u00e1t k\u00e9pez\u0151 neurog\u00e9n h\u00f3lyag egy gy\u0171jt\u0151fogalom, mely\n                    mag\u00e1ban foglal minden, relev\u00e1ns neurol\u00f3giai k\u00f3rk\u00e9p talaj\u00e1n kialakult\n                    vizelett\u00e1rol\u00e1si \u00e9s vizelet\u00fcr\u00edt\u00e9si zavart. Mivel a h\u00fagyh\u00f3lyag mellett a\n                    z\u00e1r\u00f3izomzat \u00e9s a h\u00e1ts\u00f3 h\u00fagycs\u0151 is \u00e9rintett, ezt a k\u00f3rk\u00e9pet napjainkban \u201eneurog\u00e9n\n                    als\u00f3 h\u00fagy\u00fati diszfunkci\u00f3\u201d elnevez\u00e9ssel is szok\u00e1s illetni. A k\u00f3r\u00e1llapotot a\n                    neurol\u00f3giai diszfunkci\u00f3k sz\u00e9les spektruma okozhatja, kezdve a helyi funkcion\u00e1lis\n                    zavart\u00f3l a helyi idegi s\u00e9r\u00fcl\u00e9sen \u00e1t a fels\u0151 \u00e9s als\u00f3 motoneuron-s\u00e9r\u00fcl\u00e9sig vagy a\n                    centr\u00e1lis degenerat\u00edv folyamatokig. Az elt\u00e9r\u0151 etiol\u00f3gia ellen\u00e9re a klinikai\n                    t\u00fcnetek rendszerint k\u00e9t alapvet\u0151 klinikai t\u00edpusban manifeszt\u00e1l\u00f3dhatnak:\n                    t\u00falm\u0171k\u00f6d\u0151 (fokozott detrusorkontraktilit\u00e1st okoz\u00f3 automata) h\u00f3lyag vagy\n                    alulm\u0171k\u00f6d\u0151 h\u00f3lyag form\u00e1j\u00e1ban. Tekintettel a neurog\u00e9n als\u00f3 h\u00fagy\u00fati diszfunkci\u00f3\n                    k\u00f6vetkezt\u00e9ben l\u00e9trej\u00f6v\u0151 fels\u0151 h\u00fagy\u00fati komplik\u00e1ci\u00f3kra, a k\u00f6zlem\u00e9ny egyik c\u00e9lja a\n                    betegs\u00e9g diagn\u00f3zis\u00e1t seg\u00edt\u0151 algoritmus bemutat\u00e1sa a leg\u00fajabb nemzetk\u00f6zi\n                    szakirodalmi ismeretek alapj\u00e1n. A neurog\u00e9n h\u00f3lyag kezel\u00e9se jobb\u00e1ra nem terjedhet\n                    ki a kiv\u00e1lt\u00f3 ok kezel\u00e9s\u00e9re, ez\u00e9rt a jelen \u00f6sszefoglal\u00f3 m\u00e1sik c\u00e9lja azon\n                    gy\u00f3gyszeres \u00e9s invaz\u00edv ter\u00e1pi\u00e1s beavatkoz\u00e1sok \u00f6sszefoglal\u00e1sa, melyek a fels\u0151\n                    h\u00fagyutak v\u00e9delm\u00e9t szolg\u00e1lj\u00e1k az alacsony h\u00f3lyagnyom\u00e1s fenntart\u00e1sa r\u00e9v\u00e9n. Orv\n                    Hetil. 2021; 162(4): 135\u2013143.<\/jats:p>\n                <jats:p><jats:bold>Summary.<\/jats:bold> Storage and urination are the main functions of the lower\n                    urinary tract and its lesions lead to the so-called lower urinary tract syndrome\n                    causing either urinary incontinence or retention. In untreated cases, the upper\n                    urinary tract becomes injured <jats:italic>via<\/jats:italic> a vesicoureteral reflux\n                    resulting from increased bladder pressure and resultant dilations of the ureter\n                    and the renal pelvis which predispose to infection and stone formation. Lower\n                    urinary tract storage\/urination disorders can be classified as stress\n                    incontinence, hyperactive bladder (wet\/dry) and neurogenic bladder. Neurogenic\n                    bladder which is the subject of this review, is a collective term that\n                    encompasses all urinary storage and emptying disorders which develop on the\n                    basis of neurological diseases. Being not only the bladder, but also the\n                    sphincter and posterior urethra (generally termed as the \u201cbladder outlet\u201d)\n                    affected, nowadays this condition is referred to as \u201cneurogenic lower urinary\n                    tract dysfunction\u201d. A wide range of neurological dysfunctions could contribute\n                    to the development of this condition, ranging from local dysfunction (autonomic\n                    dysreflexia) or local nerve injury to upper\/lower motoneuron injury or central\n                    degenerative processes. Regardless of the diverse etiology, the clinical\n                    symptoms eventually manifest in two major forms, <jats:italic>i.e.,<\/jats:italic>\n                    overacting (automatic bladder with increased detrusor contractility) and\n                    underactive bladder. Considering the severity of complication occurring in the\n                    upper urinary tract in response to the pathophysiological changes in the lower\n                    urinary tract, one of the aims of this paper was to present an algorithm aiming\n                    to build up a state of the art diagnosis of the disease based on current\n                    international literature data. Since treatment of the neurogenic bladder usually\n                    can not target elimination of the underlying cause, the other goal of the\n                    present paper is to summarize the pharmacological treatment regimen and invasive\n                    therapeutic interventions that protect the upper urinary tract by maintaining\n                    low pressure values in the bladder. Orv Hetil. 2021; 162(4): 135\u2013143.<\/jats:p>","DOI":"10.1556\/650.2021.31974","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T12:09:37Z","timestamp":1617106177000},"page":"135-143","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.1","source":"Crossref","is-referenced-by-count":1,"title":["A neurog\u00e9n h\u00fagyh\u00f3lyag klinikuma \u00e9s ter\u00e1pi\u00e1s lehet\u0151s\u00e9gei"],"prefix":"10.1556","volume":"162","author":[{"given":"P\u00e9ter","family":"J\u00e1romi","sequence":"first","affiliation":[{"name":"1 B\u00e1cs-Kiskun Megyei K\u00f3rh\u00e1z, Urol\u00f3giai Oszt\u00e1ly, Kecskem\u00e9t"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Bany\u00f3","sequence":"additional","affiliation":[{"name":"2 Orsz\u00e1gos Orvosi Rehabilit\u00e1ci\u00f3s Int\u00e9zet, Urodinamikai Labor, Budapest"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mih\u00e1ly","family":"Boros","sequence":"additional","affiliation":[{"name":"3 Szegedi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Seb\u00e9szeti M\u0171t\u00e9ttani Int\u00e9zet, Szeged, Pulz u. 1., 6724"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Papp","sequence":"additional","affiliation":[{"name":"1 B\u00e1cs-Kiskun Megyei K\u00f3rh\u00e1z, Urol\u00f3giai Oszt\u00e1ly, Kecskem\u00e9t"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Szab\u00f3","sequence":"additional","affiliation":[{"name":"3 Szegedi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Seb\u00e9szeti M\u0171t\u00e9ttani Int\u00e9zet, Szeged, Pulz u. 1., 6724"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jpurol.2010.02.210","article-title":"Risk factors for renal function impairment in a series of 502 patients born with spinal dysraphisms","volume":"7","author":"1 Torre","year":"2011","unstructured":"1 Torre M, Guida E, Bisio G, et al. Risk factors for renal function impairment in a series of 502 patients born with spinal dysraphisms. J Pediatr Urol. 2011; 7: 39-43.","journal-title":"J Pediatr Urol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.juro.2010.03.008","article-title":"Bladder management after spinal cord injury in the United States 1972 to 2005","volume":"184","author":"2 Cameron","year":"2010","unstructured":"2 Cameron AP, Wallner LP, Tate DG, et al. Bladder management after spinal cord injury in the United States 1972 to 2005. J Urol. 2010; 184: 213-217.","journal-title":"J Urol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1177\/1352458506071210","article-title":"Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis","volume":"13","author":"3 Nortvedt","year":"2007","unstructured":"3 Nortvedt MW, Riise T, Frug\u00e5rd J, et al. Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Mult Scler. 2007; 13: 106-112.","journal-title":"Mult Scler"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4 Nicholas RS, Friede T, Hollis S, et al. Anticholinergics for urinary symptoms in multiple sclerosis. Cochrane Database Syst Rev. 2009; (1): CD004193.","DOI":"10.1002\/14651858.CD004193.pub2"},{"key":"ref4","unstructured":"5 Urology Care Foundation. What is neurogenic bladder? Available from: https:\/\/www.urologyhealth.org\/urologic-conditions\/neurogenic-bladder [accessed: July 29, 2020]."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"975","DOI":"10.23736\/S1973-9087.17.04992-9","article-title":"Diagnosis and clinical evaluation of neurogenic bladder","volume":"53","author":"6 Amarenco","year":"2017","unstructured":"6 Amarenco G, Sheikh Isma\u00ebl S, Chesnel C, et al. Diagnosis and clinical evaluation of neurogenic bladder. Eur J Phys Rehabil Med. 2017; 53: 975-980.","journal-title":"Eur J Phys Rehabil Med"},{"key":"ref6","unstructured":"7 Allio BA, Peterson AC. Urodynamic and physiologic patterns associated with the common causes of neurogenic bladder in adults. Transl Androl Urol. 2016; 5: 31-38."},{"key":"ref7","unstructured":"8 Cameron AP. Medical management of neurogenic bladder with oral therapy. Transl Androl Urol. 2016; 5: 51-62."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S1474-4422(15)00070-8","article-title":"Lower urinary tract dysfunction in the neurological patient: clinical assessment and management","volume":"14","author":"9 Panicker","year":"2015","unstructured":"9 Panicker JN, Fowler CJ, Kessler TM. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol. 2015; 14: 720-732.","journal-title":"Lancet Neurol"},{"key":"ref9","unstructured":"10 Blok B, Castro-Diaz D, Del Popolo G, et al. European Association of Urology (EAU) Guidelines. Available from: https:\/\/uroweb.org\/guideline\/neuro-urology\/ [accessed: July 29, 2020]."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.urology.2009.02.047","article-title":"Does optimizing bladder management equal optimizing quality of life? Correlation between health-related quality of life and urodynamic parameters in patients with spinal cord lesions","volume":"74","author":"Pannek J","year":"2009","unstructured":"11 Pannek J, Kullik B. Does optimizing bladder management equal optimizing quality of life? Correlation between health-related quality of life and urodynamic parameters in patients with spinal cord lesions. Urology 2009; 74: 263-266.","journal-title":"Urology"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12 Chuang FC, Hsiao SM, Kuo HC. The Overactive Bladder Symptom Score, International Prostate Symptom Score-Storage Subscore, and Urgency Severity Score in patients with overactive bladder and hypersensitive bladder: which scoring system is best? Int Neurourol J. 2018; 22: 99-106.","DOI":"10.5213\/inj.1832554.277"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/nau.1018","article-title":"Protocol for clinical neurophysiologic examination of the pelvic floor","volume":"20","author":"Podnar S","year":"2001","unstructured":"13 Podnar S, Vodusek DB. Protocol for clinical neurophysiologic examination of the pelvic floor. Neurourol Urodyn. 2001; 20: 669-682.","journal-title":"Neurourol Urodyn"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/nau.10066","article-title":"Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies","volume":"21","author":"14 Sch\u00e4fer","year":"2002","unstructured":"14 Sch\u00e4fer W, Abrams P, Liao L, et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn. 2002; 21: 261-274.","journal-title":"Neurourol Urodyn"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15 Allert M, Jelasic F, Schneider H. Specific EMG findings in cases of neurogenic bladder and rectal disturbances. Paraplegia 1973; 10: 262-270.","DOI":"10.1038\/sc.1973.49"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16 Bacsu CD, Chan L, Tse V. Diagnosing detrusor sphincter dyssynergia in the neurological patient. BJU Int. 2012; 109(Suppl 3): 31-34.","DOI":"10.1111\/j.1464-410X.2012.11042.x"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/nau.20319","article-title":"Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury","volume":"26","author":"17 Nosseir","year":"2007","unstructured":"17 Nosseir M, Hinkel A, Pannek J. Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury. Neurourol Urodyn. 2007; 26: 228-233.","journal-title":"Neurourol Urodyn"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ucl.2014.04.008","article-title":"Videourodynamics: indications and technique","volume":"41","author":"Marks BK","year":"2014","unstructured":"18 Marks BK, Goldman HB. Videourodynamics: indications and technique. Urol Clin North Am. 2014; 41: 383-391.","journal-title":"Urol Clin North Am"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1111\/bph.12502","article-title":"TRP channels in lower urinary tract dysfunction","volume":"171","author":"19 Franken","year":"2014","unstructured":"19 Franken J, Uvin P, De Ridder D, et al. TRP channels in lower urinary tract dysfunction. Br J Pharmacol. 2014; 171: 2537-2551.","journal-title":"Br J Pharmacol"},{"key":"ref19","unstructured":"20 Burkhard FC, Bosch JL, Cruz F, et al. European Association of Urology (EAU) Guidelines. Urinary Incontinence 2020. Available from: https:\/\/uroweb.org\/guideline\/urinary-incontinence [accessed: July 29, 2020]."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.eururo.2006.03.016","article-title":"Results of a randomized, double-blind, multicenter clinical study","volume":"51","author":"21 St\u00f6hrer","year":"2007","unstructured":"21 St\u00f6hrer M, M\u00fcrtz G, Kramer G, et al. Propiverine compared to oxybutynin in neurogenic detrusor overactivity. Results of a randomized, double-blind, multicenter clinical study. Eur Urol. 2007; 51: 235-242.","journal-title":"Eur Urol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0022-5347(17)34884-X","article-title":"Prospective evaluation of terazosin for the treatment of autonomic dysreflexia","volume":"151","author":"22 Chancellor","year":"1994","unstructured":"22 Chancellor MB, Erhard MJ, Hirsch IH, et al. Prospective evaluation of terazosin for the treatment of autonomic dysreflexia. J Urol. 1994; 151: 111-113.","journal-title":"J Urol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.juro.2013.05.062","article-title":"Urodynamics and safety of the \u03b23-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction","volume":"190","author":"23 Nitti","year":"2013","unstructured":"23 Nitti VW, Rosenberg S, Mitcheson DH, et al. Urodynamics and safety of the \u03b23-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction. J Urol. 2013; 190: 1320-1327.","journal-title":"J Urol"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24 Szollar S, North J, Chung J. Antidiuretic hormone levels and polyuria in spinal cord injury. A preliminary report. Paraplegia 1995; 33: 94-97.","DOI":"10.1038\/sc.1995.22"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0404.2005.00431.x","article-title":"Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis","volume":"112","author":"25 Bosma","year":"2005","unstructured":"25 Bosma R, Wynia K, Havl\u00edkov\u00e1 E, et al. Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis. Acta Neurol Scand. 2005; 112: 1-5.","journal-title":"Acta Neurol Scand"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"19084","DOI":"10.1073\/pnas.1005333107","article-title":"Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis","volume":"107","author":"26 Everaerts","year":"2010","unstructured":"26 Everaerts W, Zhen X, Ghosh D, et al. Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis. Proc Natl Acad Sci. 2010; 107: 19084-19089.","journal-title":"Proc Natl Acad Sci"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S0022-5347(17)45030-0","article-title":"The capsaicin-sensitive innervation of the rat urinary bladder: further studies on mechanisms regulating micturition threshold","volume":"136","author":"27 Maggi","year":"1986","unstructured":"27 Maggi CA, Santicioli P, Giuliani S, et al. The capsaicin-sensitive innervation of the rat urinary bladder: further studies on mechanisms regulating micturition threshold. J Urol. 1986; 136: 696-700.","journal-title":"J Urol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S0022-5347(17)38701-3","article-title":"Cystometric evidence that capsaicin-sensitive nerves modulate the afferent branch of micturition reflex in humans","volume":"142","author":"28 Maggi","year":"1989","unstructured":"28 Maggi CA, Barbanti G, Santicioli P, et al. Cystometric evidence that capsaicin-sensitive nerves modulate the afferent branch of micturition reflex in humans. J Urol. 1989; 142: 150-154.","journal-title":"J Urol"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29 Maggi CA. The dual function of capsaicin-sensitive sensory nerves in the bladder and urethra. Ciba Found Symp. 1990; 151: 77-83.; discussion 83-90.","DOI":"10.1002\/9780470513941.ch5"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30 Bley K. Effects of topical capsaicin on cutaneous innervation: implications for pain management. Open Pain J. 2012; 6(Suppl 1): 81-94.","DOI":"10.2174\/1876386301306010081"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31 Dasgupta P, Chandiramani V, Parkinson MC, et al. Treating the human bladder with capsaicin: is it safe? Eur Urol. 1998; 33: 28-31.","DOI":"10.1159\/000019531"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/nau.24032","article-title":"Effects of early intravesical administration of resiniferatoxin to spinal cord-injured rats in neurogenic detrusor overactivity","volume":"38","author":"32 Oliveira","year":"2019","unstructured":"32 Oliveira R, Coelho A, Franquinho F, et al. Effects of early intravesical administration of resiniferatoxin to spinal cord-injured rats in neurogenic detrusor overactivity. Neurourol Urodyn. 2019; 38: 1540-1550.","journal-title":"Neurourol Urodyn"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/003655998750015287","article-title":"Intravesical resiniferatoxin for the treatment of detrusor hyperreflexia refractory to capsaicin in patients with chronic spinal cord diseases","volume":"32","author":"33 Lazzeri","year":"1998","unstructured":"33 Lazzeri M, Spinelli M, Beneforti P, et al. Intravesical resiniferatoxin for the treatment of detrusor hyperreflexia refractory to capsaicin in patients with chronic spinal cord diseases. Scand J Urol Nephrol. 1998; 32: 331-334.","journal-title":"Scand J Urol Nephrol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000075969","article-title":"Intravesical vanilloids and neurogenic incontinence: ten years experience","volume":"72","author":"34 Lazzeri","year":"2004","unstructured":"34 Lazzeri M, Spinelli M, Zanollo A, et al. Intravesical vanilloids and neurogenic incontinence: ten years experience. Urol Int. 2004; 72: 145-149.","journal-title":"Urol Int"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1016\/j.juro.2012.12.022","article-title":"OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial","volume":"189","author":"35 Nitti","year":"2013","unstructured":"35 Nitti VW, Dmochowski R, Herschorn S, et al. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol. 2013; 189: 2186-2193.","journal-title":"J Urol"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36 Majoros A, Romics M. Diagnosis and treatment of the overactive bladder. [A hiperakt\u00edv h\u00f3lyag kivizsg\u00e1l\u00e1sa \u00e9s kezel\u00e9se.] LAM 2020; 30: 131-136. [Hungarian]","DOI":"10.33616\/lam.30.013"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.eururo.2012.09.023","article-title":"EAU guidelines on surgical treatment of urinary incontinence","volume":"62","author":"37 Lucas","year":"2012","unstructured":"37 Lucas MG, Bosch RJ, Burkhard FC, et al. EAU guidelines on surgical treatment of urinary incontinence. Eur Urol. 2012; 62: 1118-1129.","journal-title":"Eur Urol"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38 Deng H, Liao L, Wu J, et al. Clinical efficacy of intravesical electrical stimulation on detrusor underactivity: 8 years of experience from a single center. Medicine (Baltimore) 2017; 96: e8020.","DOI":"10.1097\/MD.0000000000008020"},{"key":"ref38","unstructured":"39 Bany\u00f3 T. Current issues in neurourology. [A neurourol\u00f3gia aktu\u00e1lis k\u00e9rd\u00e9sei.] Ideggy\u00f3gy Szle. 2006; 59: 76-84. [Hungarian]"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/162\/4\/article-p135.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/162\/4\/article-p135.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T15:32:56Z","timestamp":1698766376000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/162\/4\/article-p135.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,24]]},"references-count":39,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1556\/650.2021.31974","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,24]]}}}